tiprankstipranks
Ember Therapeutics Inc (EMBT)
OTHER OTC:EMBT
US Market

Ember Therapeutics (EMBT) Income Statement

4 Followers

Ember Therapeutics Income Statement

Last quarter (Q ), Ember Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Ember Therapeutics's net income was $-1.35K. See Ember Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 14Dec 13Dec 12
Total Revenue
-$ 0.00$ 0.00$ 0.00
Cost of Revenue
-$ 0.00$ 0.00$ 0.00
Gross Profit
-$ 0.00$ 0.00$ 0.00
Operating Expense
$ 13.93K$ 17.42K$ 11.08K$ 7.87K
Operating Income
$ -13.93K$ -17.42K$ -11.08K$ -7.87K
Net Non Operating Interest Income Expense
$ -6.17K$ -5.82K$ -5.26K$ -4.92K
Other Income Expense
----
Pretax Income
$ -20.09K$ -23.24K$ -16.33K$ -12.79K
Tax Provision
----
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -20.09K$ -23.24K$ -16.33K$ -12.79K
Basic EPS
$ >-0.01$ -0.01$ 0.00$ 0.00
Diluted EPS
$ >-0.01$ -0.01$ 0.00$ 0.00
Basic Average Shares
$ 14.83M$ 3.71M$ 3.71M$ 3.71M
Diluted Average Shares
$ 14.83M$ 3.71M$ 3.71M$ 3.71M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 13.93K$ 17.42K$ 11.08K$ 7.87K
Net Income From Continuing And Discontinued Operation
$ -20.09K$ -23.24K$ -16.33K$ -12.79K
Normalized Income
$ -20.09K$ -23.24K$ -16.33K$ -12.79K
Interest Expense
$ 6.17K$ 5.82K$ 5.26K-
EBIT
$ -13.93K$ -17.42K$ -11.08K$ -7.87K
EBITDA
$ -13.93K$ -17.42K$ -11.08K$ -7.87K
Currency in USD

Ember Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis